Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vifa1g00584 | ATGTTACTTCCGTGTTTGATGGAAATCATGGCGAGGAAGAAACAGAATAACTGTTGGATTCACGTTACAAGAGTAGCAAATGGTCTTTTGTGGAAATGCAATTATTGTGAGTTTACTTTTGAGGGTAGTACTAGTGCTTCAAAAGTTAAAGCACACTTGGGGCTGGATGGCAAAACAGGAAACATTACACCATGCTCTTATCATGCTCACCAACAAGTTCTCAACAATATCGCATCCTCTTCAAGTGAGAACTTGAGCATCCGTGATAGAAGTATCTTTGAGAGTAAGATTAATAACTTAAAAGGAATGGTTATTGATCTAGAATGTGAGGAAAATGATATTGCAAAACAAACTCAATGGTTGGAGTCTCGGGGCAGAAAGCGCAAGCCTGAAGTTGATGCATGGATAAAAGAATTACATGAATTGAAAGAAAGAGTGGATGCTATTAATAACTTGGATGACATGAATGAGTTGTTCAAAGATATGAAACGACACAAGGGAGAAAAACCTCTCACTTTGTCCACTGAATTTGTCGGGAAAGAATTAGACTTTAATATCAAGAAAGTGATTCAACTTCTAAATGATGACCAAGTTTTTGTTATCGGTATATATGGAATGGGAGGAGTGGGAAAAACTTTACTTGCTACTCTTGTGGAGAATGAAATAAAAAAGAAAAGAACTTTCAATGATGTGTTTTGGGTCACTGTTTCTCCCAATTTTACCATCTCAAAACTGCAATACGATATCGCAAAACGAATAGGCGTGGAGCTTGATGAAGACAATGAGAGAATTAGAGCAAACAAATTGTCGACGACGTTGGAGACAAAGGAGAAGTCTGTTCTTATTTTGGATGATGTTTGGAGATACATTGATTTGGAAAAGGTGGGTGTTTCTACAAAAGTGAATGGAATTAAAGTGATTCTCACAACGCGTTTGAAACATGTGTGTCAACAGATGGATTGCTTGCCAAGTCATATGATAAAAGTGATACCTCTCTACGATGTAGATGAAGGTTGGGAGTTATTTAAGGTAAAACTTGGACACTACGGAACACCTGCTACACTCTCCCCTGAAATTGAAACTGTTGCAAGAGATATTGTAGATCGGTTTGCGGGTTTGCCGCTTGGAATCAGTGTGATGGCTAGAACCATGAAAGGAATTGATGAGATTGATCAATGGAAACATTCATTGAATAAACTTAACAAATTGGAAATGGGACAAGAGGTGATAGAAGAAGTTTTCAAGGTATTAAAACGTAGTTATGATAATTTGATGGAAAAAGACTTGCGAAACTGTTTTTTGTATTGTGCACTACTATCTAGTTACGAAGAGAATGACAGAGAAGAAACGATTATGAAACTTGTTGACAATGGACTGATAAATGGGAATAGGTGTTTGCAAGAAATATTCGATGAAGGGCAAACCATATTAGATAAGCTCAGATCCCACAGTTTGATGAGTGGTTTTGATCATTCATTTGAATTTAATTATCGCTTGGTGATAGACACGGCATGTTATATTATGAAAGAAAGTAAGAGAAATGCTATGGTGAAATTAGAGAACGAATTGACAAAGACAAACATCACGCATGAATGGGCCGCTGATTTAGAGTTTGTTCATATGTGGGCTGGTGAATCAAATGATATTGAAGAAATTCCAGAGGGCATGTCACCTTATTGTCCGAGGTTGTCCACCTTGATTATAAATCAATTGGCCGTTCAACATATTCCAGAGAGTTTTTTCAAATGTATGAATACCCTAACAATACTCGATCTGTCATATAGTAAAAGACTAGAATGCTTGCCAAATTCTATCAGTAAGATGAAGTGTCTTGTTTCTTTAGTACTAATAGAATGTAATTCACTTAAACATGTGCCGCCATTAGGAGAATTGAAGGTATTGTCAAGATTGGTTCTTTCAAATTGTTCCATTGAAGAACTACCACAAGGTTTGGATAAGCTACAGAATTTGAAATGGCTTGATCTATCTTTCAACAAGAGTTTGAATTTTGAATTAGGGTCTTTGAATTTGACCAAAATACAATACCTTGATCTCCAAGGTACTCGTACAATGATTACTGTCGAAGATATTCAAAGAATGACTGTGTTGGAATGTTTTGGAGGTGCTTTTAACTGCAAACATTACAACCAGTACTTGGAGAAATATCTTGGCACGCGATCTCGGCTCCAAGCATATTATCTCATATTAGGAAATGTATATGGTGAATCAAGAAGTGTTTTGCGGAATGATATTTATTTGAAAGCATTTGATCCAAATGATCCTGAAGTTATGACTATACTATTTAGAGACTGTGGTCATTTCTCCCACATACTACCTAAAGATCTTACATGTTTGAATATAGATAAAAATGATCATTGGGTTTGCTTATGTGATGCTCTCTCATGTAACACTAGTTCTTCTTTGAAGAAAATTGGAGCTTATAATTGCCAACAGCTAGAGAGGTTGTTTTGTTTATCTGATTCTTGTTCCTTTTGTACCAAGATTCACAACCTTGAAATGTTGGAACTTGAGAGTTTGGAAAGGTTAACCGTCATTGACGTTAATGCAAGACAAACTTGGTCATTGGGTGGCATATTCTCTTGTCTAAAAAGTATTTATGTTTTTGAGTGCCATTTGATAGAGAAGTTAATTACACCAAAGTTAGTTGGACAAGTTCAAAATCTGGAAATAATTTCAGTAAGGCGTTGCAATTCAATGAAAGAGATATTAGCGGTGAGCGACGACATCAGACTTCCCAAGCTAAAAAGATTGATATTGGATTATTTACCACAATTGAAGATTAAAAAGAAGAAGGGAAAAGGATCCAAATCTGATTATGCCGCGCCTCATCTCACAATCCAGGTACCTTCTACAAATGGGTCTTCGGAGCAGAATTTGTTGGGAGAAGCTGGATTTGGTTGTGTCTACAAAGGTTTGCTAGATGGAAGAGAAGTAGCTGTAAAACAGCTTAAAATTGGTAGTGGACAAGGGGAGCGTGAGTTCAGAGCAGAAGTTGAGACTATTAGTCGAGTACATCATCGTAATCTGGTTTCTTTGGTTGGTTACTGTATATCTGTGCATCAAAGATTGCTCGTCTATGACTTTGCTCTGGTTTCAGATTTCAGGCTTGCGAAATTAGTATTGGATTCAAACACACATGTAACTACACGGTTTGTCAATGCCTCTCAGCCAATTGGTGACAAGAGCCTGGTTGAATGGGTTCCAGATTTAAATAGTATCTTATCTTTATTTCAAGGCTCAGATACTGAGGACTTTGAAACTTTGGTGGATCCAAGACTGGAAAAGAACTGCAACAGAAACGAAATGTTTAGAATGATTGAGGCCGCGACAGCCTGCGTGCGTCACTCTTCAGTTAAGAGGCCACAGATGAGTCAGGTTATGAGAGCTTTTGATTCCATGGCCGAGTTTTCGGATCTGAATAACGGAATGAAACCGAGGCAGAGTTCAGAGTTTGATTTTGCACAACAACTTGCACAGACCAGAATGCCGAGAAGGAAGGCTTTTGGAAGCCAAGATAGTTCCAGTTTCTTTAATGATTCTCAAAGTAGCTCTGGAAGTAGGAATCAAGACTCTACAACTATGCTCCCACAAAATAAATCTAGGCCTTGGAACGTTCGAGACGACCCTTTATAG | 3654 | 0.3755 | MLLPCLMEIMARKKQNNCWIHVTRVANGLLWKCNYCEFTFEGSTSASKVKAHLGLDGKTGNITPCSYHAHQQVLNNIASSSSENLSIRDRSIFESKINNLKGMVIDLECEENDIAKQTQWLESRGRKRKPEVDAWIKELHELKERVDAINNLDDMNELFKDMKRHKGEKPLTLSTEFVGKELDFNIKKVIQLLNDDQVFVIGIYGMGGVGKTLLATLVENEIKKKRTFNDVFWVTVSPNFTISKLQYDIAKRIGVELDEDNERIRANKLSTTLETKEKSVLILDDVWRYIDLEKVGVSTKVNGIKVILTTRLKHVCQQMDCLPSHMIKVIPLYDVDEGWELFKVKLGHYGTPATLSPEIETVARDIVDRFAGLPLGISVMARTMKGIDEIDQWKHSLNKLNKLEMGQEVIEEVFKVLKRSYDNLMEKDLRNCFLYCALLSSYEENDREETIMKLVDNGLINGNRCLQEIFDEGQTILDKLRSHSLMSGFDHSFEFNYRLVIDTACYIMKESKRNAMVKLENELTKTNITHEWAADLEFVHMWAGESNDIEEIPEGMSPYCPRLSTLIINQLAVQHIPESFFKCMNTLTILDLSYSKRLECLPNSISKMKCLVSLVLIECNSLKHVPPLGELKVLSRLVLSNCSIEELPQGLDKLQNLKWLDLSFNKSLNFELGSLNLTKIQYLDLQGTRTMITVEDIQRMTVLECFGGAFNCKHYNQYLEKYLGTRSRLQAYYLILGNVYGESRSVLRNDIYLKAFDPNDPEVMTILFRDCGHFSHILPKDLTCLNIDKNDHWVCLCDALSCNTSSSLKKIGAYNCQQLERLFCLSDSCSFCTKIHNLEMLELESLERLTVIDVNARQTWSLGGIFSCLKSIYVFECHLIEKLITPKLVGQVQNLEIISVRRCNSMKEILAVSDDIRLPKLKRLILDYLPQLKIKKKKGKGSKSDYAAPHLTIQVPSTNGSSEQNLLGEAGFGCVYKGLLDGREVAVKQLKIGSGQGEREFRAEVETISRVHHRNLVSLVGYCISVHQRLLVYDFALVSDFRLAKLVLDSNTHVTTRFVNASQPIGDKSLVEWVPDLNSILSLFQGSDTEDFETLVDPRLEKNCNRNEMFRMIEAATACVRHSSVKRPQMSQVMRAFDSMAEFSDLNNGMKPRQSSEFDFAQQLAQTRMPRRKAFGSQDSSSFFNDSQSSSGSRNQDSTTMLPQNKSRPWNVRDDPL | 1217 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vifa1g00584 | 1217 | Gene3D | - | 334 | 425 | IPR042197 | - | |
Vifa1g00584 | 1217 | Gene3D | Transferase(Phosphotransferase) domain 1 | 1057 | 1157 | - | - | |
Vifa1g00584 | 1217 | Gene3D | Phosphorylase Kinase; domain 1 | 937 | 1035 | - | - | |
Vifa1g00584 | 1217 | Gene3D | Ribonuclease Inhibitor | 521 | 733 | IPR032675 | - | |
Vifa1g00584 | 1217 | Coils | Coil | 509 | 529 | - | - | |
Vifa1g00584 | 1217 | ProSiteProfiles | Protein kinase domain profile. | 961 | 1217 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa1g00584 | 1217 | Pfam | NB-ARC domain | 186 | 423 | IPR002182 | GO:0043531 | |
Vifa1g00584 | 1217 | SUPERFAMILY | Protein kinase-like (PK-like) | 951 | 1137 | IPR011009 | - | |
Vifa1g00584 | 1217 | Gene3D | Ribonuclease Inhibitor | 778 | 936 | IPR032675 | - | |
Vifa1g00584 | 1217 | PRINTS | Disease resistance protein signature | 652 | 668 | - | - | |
Vifa1g00584 | 1217 | PRINTS | Disease resistance protein signature | 200 | 215 | - | - | |
Vifa1g00584 | 1217 | PRINTS | Disease resistance protein signature | 273 | 287 | - | - | |
Vifa1g00584 | 1217 | PRINTS | Disease resistance protein signature | 370 | 384 | - | - | |
Vifa1g00584 | 1217 | SUPERFAMILY | P-loop containing nucleoside triphosphate hydrolases | 182 | 436 | IPR027417 | - | |
Vifa1g00584 | 1217 | ProSiteProfiles | Zinc finger BED-type profile. | 13 | 77 | IPR003656 | GO:0003677 | |
Vifa1g00584 | 1217 | PANTHER | NB-ARC DOMAIN-CONTAINING PROTEIN-RELATED | 118 | 1091 | - | - | |
Vifa1g00584 | 1217 | FunFam | Adenine nucleotide alpha hydrolase-like domain kinase | 933 | 1035 | - | - | |
Vifa1g00584 | 1217 | SMART | tyrkin_6 | 961 | 1137 | IPR020635 | GO:0004713|GO:0006468 | |
Vifa1g00584 | 1217 | MobiDBLite | consensus disorder prediction | 1167 | 1217 | - | - | |
Vifa1g00584 | 1217 | Gene3D | - | 155 | 327 | IPR027417 | - | |
Vifa1g00584 | 1217 | Coils | Coil | 132 | 152 | - | - | |
Vifa1g00584 | 1217 | SMART | AAA_5 | 197 | 332 | IPR003593 | GO:0016887 | |
Vifa1g00584 | 1217 | MobiDBLite | consensus disorder prediction | 1173 | 1207 | - | - | |
Vifa1g00584 | 1217 | SUPERFAMILY | L domain-like | 545 | 931 | - | - | |
Vifa1g00584 | 1217 | Pfam | Protein tyrosine and serine/threonine kinase | 965 | 1039 | IPR001245 | GO:0004672|GO:0006468 | |
Vifa1g00584 | 1217 | FunFam | Probable disease resistance protein At1g61300 | 163 | 322 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vifa1g00584 | Vifa-Chr1 | 99008280 | 99013446 | Dispersed/Proximal |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vifa1g00584 | 1036 | 1196 | Trihelix Transcription Factor Family | AT5G38560 | 48.293 | 9.35e-42 | 162 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_PERK-1 | Vifa1g00584 | NB-ARC | 6.7e-48 | CL0023 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vifa1g00584 | - | - | mtr:25497664 | 1030.39 |